☰

Emily P. Harrington, B.Sc. - Publications

Affiliations: 
Pediatric University of California, San Francisco, San Francisco, CA 
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Harrington EP, Bergles DE, Calabresi PA. Immune cell modulation of oligodendrocyte lineage cells. Neuroscience Letters. 134601. PMID 31693930 DOI: 10.1016/J.Neulet.2019.134601  0.436
2014 Fancy SP, Harrington EP, Baranzini SE, Silbereis JC, Shiow LR, Yuen TJ, Huang EJ, Lomvardas S, Rowitch DH. Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer. Nature Neuroscience. 17: 506-12. PMID 24609463 DOI: 10.1038/Nn.3676  0.697
2014 Fancy SPJ, Harrington EP, Baranzini SE, Silbereis JC, Shiow LR, Yuen TJ, Huang EJ, Lomvardas S, Rowitch DH. Erratum: Corrigendum: Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer Nature Neuroscience. 17: 1841-1841. DOI: 10.1038/Nn1214-1841A  0.565
2012 Meijer DH, Kane MF, Mehta S, Liu H, Harrington E, Taylor CM, Stiles CD, Rowitch DH. Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. Nature Reviews. Neuroscience. 13: 819-31. PMID 23165259 DOI: 10.1038/Nrn3386  0.601
2011 Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ, Huang EJ, Nusse R, Franklin RJ, Rowitch DH. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nature Neuroscience. 14: 1009-16. PMID 21706018 DOI: 10.1038/Nn.2855  0.684
2011 Mehta S, Huillard E, Kesari S, Maire CL, Golebiowski D, Harrington EP, Alberta JA, Kane MF, Theisen M, Ligon KL, Rowitch DH, Stiles CD. The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell. 19: 359-71. PMID 21397859 DOI: 10.1016/J.Ccr.2011.01.035  0.658
2010 Harrington EP, Zhao C, Fancy SP, Kaing S, Franklin RJ, Rowitch DH. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Annals of Neurology. 68: 703-16. PMID 20853437 DOI: 10.1002/Ana.22090  0.714
2010 Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJ. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Experimental Neurology. 225: 18-23. PMID 20044992 DOI: 10.1016/J.Expneurol.2009.12.020  0.707
Show low-probability matches.